sciclone pharmaceuticals inc
Former Chief Executive Officer of China Operations and Director, SciClone Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Mr. Mark Lotter is an Industry and Business Advisor and Partner at Greater Pacific Capital LLP. He was the Chief Executive Officer of China Operations at SciClone Pharmaceuticals, Inc., from April 2011 to December 14, 2012. Mr. Lotter was the Chief Executive Officer, President, and Director at NovaMed Pharmaceuticals Inc. Prior to founding NovaMed, Mr. Lotter served as Vice President, Commercial Operations of AstraZeneca China. He was largely responsible for turning ...
950 Tower LanePhone: 650-358-3456
Foster City, California 94404
Board Members Memberships*There is no Board Members Memberships data available.
The University of KwaZulu-Natal
University of South Africa
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|